| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778406 | European Urology | 2018 | 9 Pages |
Abstract
Routine 2-yr postradiotherapy biopsy is not recommended but can be considered in selected patients with unfavourable post-treatment prostate-specific antigen levels who are suitable for early salvage treatments.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Antoine Kass-Iliyya, Gordana Jovic, Claire Murphy, Cyril Fisher, Isabel Syndikus, Chakiath Jose, Christopher D. Scrase, John D. Graham, David Nicol, Matthew R. Sydes, David Dearnaley,